The current price of ELV is $428.76 — it has decreased by 0.75% since the previous close. Data as of Nov 6, 2026.
ELV is up 0.88% over the past week, up 7.17% over the past month and up 36.36% over the past year. The price is above its 200-day moving average of $373.35.
Analysts' average 12-month price target for ELV is $466.69, which implies 8.85% upside from the current price. Individual estimates range from $395.00 to $523.00.
Of the 22 analysts covering Elevance Health Inc., 3 rate it a strong buy, 12 rate it a buy and 7 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Elevance Health Inc. has a market capitalization of $92.98B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Elevance Health Inc. posted earnings of $6.99 per share against an estimate of $4.71, beating expectations by 48.41%. Upcoming reports are listed in the earnings calendar.
Elevance Health Inc. reported revenue of $50.44B in its most recent quarter, which has increased by 0.70% compared with the same quarter a year earlier. Analysts had expected $49.28B.
Yes. Elevance Health Inc. pays dividends quarterly. The latest payment of $1.72 per share has a payment date of Dec 18, 2026, which corresponds to a dividend yield of 1.60%.
Companies most comparable to Elevance Health Inc. include UnitedHealth Group Incorporated, CVS Health Corp., Cigna Corporation, Humana Inc. and Centene Corp.
In the latest trading session ELV moved between $421.47 and $429.78, a range of 1.94% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Elevance Health Inc. shows a buy rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Elevance Health Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ELV has traded between $274.84 and $450.69. The current price is 4.87% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.